ORLANDO, Fla., Aug. 1 /PRNewswire-FirstCall/ -- Telzuit Medical Technologies, Inc. announced today that the audit committee of the Company’s Board of Directors has selected the accounting firm Cross, Fernandez & Riley LLP as their new independent auditor.
Telzuit reassessed their independent auditor relationship as they were approaching product launch. Jerry Balter, CFO of Telzuit commented, “We simply needed to retain a firm with an Orlando presence and with the available resources to support the Company’s business requirements while ensuring we received the finest audit support available. Cross, Fernandez & Riley has a solid reputation for professionalism and service with proven expertise with public companies. When you add in their membership is the BDO Seidman Alliance, this is clearly the best choice for us at this stage.”
About Telzuit Medical Technologies, Inc.
Telzuit Medical Technologies, Inc. is dedicated to providing advanced mobile medicine for people worldwide. The first step in this mission will initially take the form of our state-of-the-art, FDA approved, STATPATCH Wireless Heart Monitor. This is a full 12-lead, completely wireless, Holter monitor, which is new to the marketplace. Telzuit is also building its own dedicated intranet as a platform to handle several of the products it will be releasing, including its initial product, the STATPATCH Wireless Heart Monitor System. Telzuit is based in Orlando, Florida. For more information on the company, its business model, and its products can be found on its website: http://www.telzuit.com.
Forward Looking Statement: Except for factual statements made herein, the information contained in this press release consists of forward-looking statements that involve risks and uncertainties, including the effect of changing economic conditions, competition within the health products industry, customer acceptance of products, and other risks and uncertainties. Such forward-looking statements are not guarantees of performance, and Telzuit results could differ materially from those contained in such statements. These forward-looking statements speak only as of the date of this release, and Telzuit undertake no obligation to publicly update any forward-looking statements to reflect new information, events or circumstances after the date of this release.
Contact: Telzuit Medical Technologies, Inc. James Tolan Co-Founder, Telzuit Medical Technologies, Inc. 407-354-1222
Telzuit Medical Technologies, Inc.
CONTACT: James Tolan, Co-Founder of Telzuit Medical Technologies, Inc.,+1-407-354-1222
Web site: http://www.telzuit.com//
